NEW YORK (GenomeWeb) – Ambry Genetics announced today that it will partner with Invicro to provide customized genomics and imaging services for the biotechnology and pharmaceutical industry, with a specialized focus on oncology and neurodegenerative diseases.

The partnership will combine Invicro's imaging services and software with Ambry's genomics services to expedite new drug discovery and development.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.